Angela Mastronuzzi will serve as President, with Riccardo Masetti as Vice President. The Board members will include Andrea Zibaldo, Michela Casanova, Francesca Rossi, Teresa Perillo, and Antonella Colombini.
Dec 5, 2024, 17:49
AIEOP’s new 2024-2027 Board of Directors
AIEOP announced the appointment of its new Board of Directors for the 2024-2027 term.
AIEOP, the Associazione Italiana Ematologia Oncologia Pediatrica (Italian Association of Pediatric Hematology and Oncology), is an organization dedicated to the advancement of pediatric hematology and oncology in Italy. AIEOP brings together healthcare professionals, researchers, and institutions dedicated to the treatment, care, and research of hematological and oncological diseases in children and adolescents.
AIEOP works to improve the diagnosis, treatment, and follow-up of pediatric patients with blood disorders and cancers through standardized protocols and treatment guidelines. AIEOP organizes scientific meetings, workshops, and educational programs for healthcare professionals on the latest research and treatment approaches in pediatric hematology and oncology.
Angela Mastronuzzi – President
Angela Mastronuzzi is pediatric hematologist-oncologist and the Head of Neuro-Oncology Unit at Bambino Gesù Children’s Hospital (Italy). She is also a professor at the UniCamillus International Medical University, and a Board Member of AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica). Her main fields of interest are CNS tumors and innovative therapies. Angela will serve as President of AIEOP starting December 1st, 2024.
Riccardo Masetti – Vice President
Riccardo Masetti is an Associate Professor at the Università di Bologna. He is also the Medical Director Pediatrics at Sant’Orsola Malpighi Hospital Bologna. He earned his PhD in Bone Marrow Transplant Biotechnology from the University of Perugia. He is the Vice President of AIEOP.
Andrea Zibaldo – Board Member
Andrea Zibaldo is a Clinical Research Nurse at the Santobono-Pausilipon National Hospital Trust. Previously, he was a Pediatric Oncology Nurse at Cambridge University Hospitals NHS Foundation Trust and was a Registered Nurse at Great Western Hospitals NHS Foundation Trust. He earned his Master’s degree from the London South Bank University and Università Telematica Pegaso.
Michela Casanova – Board Member
Michela Casanova is a pediatric oncologist based in Milan, Italy, with a focus on pediatric solid tumors, particularly Soft Tissue Sarcomas and New Drug Development. She serves as the chairman of the New Drug Group for the Italian Paediatric Haematology and Oncology Association. Additionally, she is a member of the Executive Committee and co-chair of the Solid Tumour Committee of ITCC (Innovative Therapies for Children with Cancer) and a board member of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Teresa Perillo – Board Member
Teresa Perillo is a Medical Director in Pediatric Oncology at Policlinico di Bari, where she has been working since 2018. With experience in treating pediatric cancer patients, she is also responsible for coordinating the Pediatric Neuro-Oncology team. Her role includes both clinical practice and ongoing specialization in pediatric oncology.
Francesca Rossi – Board Member
Francesca Rossi is a Full Professor of Pediatrics at the University of Campania Luigi Vanvitelli. She leads the Pediatric Onco-Hematology research group, focusing on pediatric cancer and hematology. Dr. Rossi also serves as the Department Referent for Research Quality, Research Activities, Third Mission Activities, the VQR Procedure, and the IRIS database, overseeing various research and academic initiatives.
Antonella Colombini – Board Member
Antonella Solombini, MD, is a pediatrician and the Head of the Outpatients Clinic at the Pediatric Clinic of the Fondazione MBBM at Ospedale San Gerardo in Monza (MB), Italy.
“IT’S OFFICIAL – AIEOP’s new 2024-2027 Board of Directors has taken office!
We welcome and thank them as they embark on leading us for these next three years! And we are also thrilled to announce the nomination of Riccardo Masetti as our new Vice President!
With focus on collaborations between centers and investment in research, here are the objectives of the new mandate:
– Involvement of young people
– Strengthening the Clinical Trial Office
– Enhancement of healthcare professionals in AIEOP centers
– Consolidation of relationships with parent associations through
– Incentivization of Molecular Tumor Boards
– Histopathological and molecular centralization, strengthening of existing networks and adoption of technological equipment for the best data exchange in compliance with GDPR privacy
– Creation of a meeting and discussion space through web and social media
Please join us in welcoming them! The future is bright.
President: Angela Mastronuzzi
Vice President: Riccardo Masetti
Board Members:
Andrea Zibaldo
Michela Casanova
Francesca Rossi
Teresa Perillo
Antonella Colombini.”
“Very proud to be leading AIEOP these next 3 years. Thank you to my new fellow board members and for everyone’s support!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 5, 2024, 17:49
Dec 5, 2024, 17:33
Dec 5, 2024, 17:18